Presentation is loading. Please wait.

Presentation is loading. Please wait.

Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.

Similar presentations


Presentation on theme: "Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and."— Presentation transcript:

1 Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24):2518-2531. doi:10.1001/jama.2014.6634 End-Stage Renal Disease (ESRD) Associated With Percentage Change in Estimated GFR During a 2-Year Baseline PeriodValues trimmed at less than −70% change (0.22% and 0.055% of the study population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively) and greater than 40% change (5.9% and 0.51% of the population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively). In the top 2 panels, the diamonds indicate the reference point of 0% change in estimated GFR. Figure Legend:

2 Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24):2518-2531. doi:10.1001/jama.2014.6634 Risk of End-Stage Renal Disease by Change in Estimated Glomerular Filtration Rate (GFR) During a 2-Year Baseline Period, First Estimated GFR, and Subsequent Follow-upBaseline risk is calculated for participants with 0% change in estimated GFR, estimated GFR of 50 mL/min/1.73 m 2, age of 60 years, male sex, nonblack race, systolic blood pressure of 130 mm Hg, total cholesterol level of 5 mmol/L, and without diabetes or a history of cardiovascular disease. Figure Legend:

3 Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24):2518-2531. doi:10.1001/jama.2014.6634 All-Cause Mortality Associated With Percentage Change in Estimated GFR During a 2-Year Baseline PeriodValues trimmed at less than −70% change (0.30% and 0.050% of the study population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively) and greater than 40% change (5.8% and 0.46% of the population for estimated GFR <60 mL/min/1.73 m 2 and ≥60 mL/min/1.73 m 2, respectively). In the top 2 panels, the diamonds indicate the reference point of 0% change in estimated GFR. Figure Legend:

4 Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality JAMA. 2014;311(24):2518-2531. doi:10.1001/jama.2014.6634 Risk of All-Cause Mortality by Change in Estimated Glomerular Filtration Rate (GFR) During a 2-Year Baseline Period, First Estimated GFR, and Subsequent Follow-upBaseline risk is calculated for participants with 0% change in estimated GFR, estimated GFR of 50 mL/min/1.73 m 2, age of 60 years, male sex, nonblack race, systolic blood pressure of 130 mm Hg, total cholesterol level of 5 mmol/L, and without diabetes or a history of cardiovascular disease. Figure Legend:


Download ppt "Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and."

Similar presentations


Ads by Google